Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Garcia

Hand Surgery Charlotte, NC Medical Doctor

NPI 1063626877 CMS profile 564155

1915 Randolph Rd, Charlotte, NC 28207

Open in the dashboard

General payments

$381,169

369 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Garcia of Charlotte, NC is reported in the CMS Open Payments database as having received $381,169 across 369 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,582 58
2024 General $32,109 36
2023 General $59,396 57
2022 General $44,101 48
2021 General $70,921 72
2020 General $33,345 23
2019 General $56,714 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Garcia
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Ryan Garcia were reported at $84,582. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Ryan Garcia Hand Surgery median Middle half National median
2019 $56,714 $383 $106–$1,905 $163
2020 $33,345 $172 $51–$1,268 $114
2021 $70,921 $263 $71–$1,591 $132
2022 $44,101 $336 $87–$1,938 $149
2023 $59,396 $233 $81–$1,114 $160
2024 $32,109 $258 $88–$1,203 $164
2025 $84,582 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $312,023 288 payments
  2. Acumed LLC $66,938 60 payments
  3. CurvaFix, Inc. $500 1 payment
  4. Synthes GmbH $500 1 payment
  5. AxoGen $367 4 payments
  6. Field Orthopaedics Pty Ltd $133 1 payment
  7. Trice Medical, Inc. $131 1 payment
  8. Osteomed LLC $122 1 payment
  9. Endo Pharmaceuticals Inc. $104 2 payments
  10. Ossur Americas., Inc $77 2 payments
  11. Other $274 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $225,137 85 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $98,510 26 payments
  3. Travel and Lodging $47,350 148 payments
  4. Food and Beverage $8,825 105 payments
  5. Honoraria $500 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $500 1 payment
  7. Education $212 2 payments
  8. Royalty or License $133 1 payment
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $158,457 107 payments
  2. Integra Recon-Skin And Wound $158,294 105 payments
  3. FLOWABLE $76,465 71 payments
  4. BILAYER WOUND MATRIX (BWM) $76,465 71 payments
  5. INTEGRA WOUND MATRIX (IWM) $75,825 63 payments
  6. IDRT $75,161 61 payments
  7. INTEGRA MESHED BILAYER WOUND MATRIX $38,591 54 payments
  8. INTEGRA WOUND MATRIX (THIN) $37,827 51 payments
  9. Hand Fracture System $31,076 7 payments
  10. Anatomic Radial Head System $30,748 7 payments
  11. Other $284,372 445 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

101

Median for Hand Surgery: 118

Drug cost

$394

Median for Hand Surgery: $615

Branded share of claims

36.6%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 37 $228
Cephalexin Generic 39 $123
Tramadol Hcl Generic 11 $23
Meloxicam Generic 14 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 109 billing codes

Paid by Medicare

$176,305

Of which drugs: $3,281

Medicare patients

417

Average age 74

Services billed

1,965

235 women, 182 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 64%
Depression 27%
Ischemic heart disease 26%
Diabetes 25%
Chronic kidney disease 21%
Osteoporosis 18%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 159 629 $3,257
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 17 30 $25

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

369 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record